Behçet’s disease and hearing loss

Ak, Erdinç; Harputluoğlu, Uğur; Oğhan, Fatih; Baykal, Bahadýr

doi:10.1016/j.anl.2003.07.006

Cited by 42 publications

(28 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In our study, sensorineural hearing loss was observed in only three patients (9.3%). These cases were bilateral and very mild, and were compatible with the typical descending curve audiogram as noted in some studies in the literature [24,25].…”

Section: Discussionsupporting

confidence: 88%

Evaluation of hearing results in Behçet's disease

Bayraktar

Aghayarov

Doğan

et al. 2019

The European Research Journal

View full text Add to dashboard Cite

Objectives: Behçet's disease is an inflammatory rheumatic disease with recurrent scarring in the oral and genital area, as well as skin, eye, joint, vein, and nerve involvement. The aim of the study was to investigate the level of hearing in Behçet's disease and whether there is a change in hearing levels as the level of the disease increases. Methosd: In this study we examined 32 patients with Behçet's disease and 50 healthy volunteers. All patients were evaluated with audiometry, tympanometry and acoustic reflex tests, as well as detailed ear, nose, and throat examinations. Results: Sensorineural hearing loss was observed in 9.3% of the patients with Behçet's disease, according to the audiological data, and all patients were bilateral. We also observed sensorineural hearing loss to be the fifth most common symptom in our study. Especially in high frequencies, there was positive correlation between hearing levels and disease exposure time (p < 0.05). Conclusions: We think that the audiological examinations should be included in the routine checkups of Behçet's patients. In addition, a follow-up assessment of the hearing level of these patients with high frequency audiometry may be more meaningful.

show abstract

Section: Discussionsupporting

confidence: 88%

Evaluation of hearing results in Behçet's disease

Bayraktar

Aghayarov

Doğan

et al. 2019

The European Research Journal

View full text Add to dashboard Cite

show abstract

“…The rates of SNHL reported in the literature are 29.5-55% in rheumatoid arthritis [Kastanioudakis et al, 1995;Salvinelli et al, 2004], 24-55% in Behçet's disease [Ak et al, 2004;Evereklioğlu et al, 2001;Pollack et al, 2001], 46% in the Sjögren syndrome [Tumiati et al, 1997] and 58% in systemic lupus erythematosus [Andonopoulos et al, 1995]. SNHL in rheumatic diseases is bilateral, especially at high frequencies.…”

Section: Discussionmentioning

confidence: 99%

Cochleovestibular Dysfunction in Ankylosing Spondylitis

Erbek

Erbek²,

Yılmaz³

et al. 2006

Audiol Neurotol

View full text Add to dashboard Cite

Ankylosing spondylitis (AS) is a rheumatic disease characterized by chronic inflammation. The aim of this study was to evaluate the functions of the cochlea and the vestibular system in patients with AS. The study group consisted of 32 patients with AS and 30 healthy volunteers as a control group. Otorhinolaryngologic examinations were performed in all patients together with pure-tone audiometry, speech tests, impedancemetry, transient evoked otoacoustic emission (TEOAE) and electronystagmography (ENG). A significant difference was found between the 2 groups with regard to pure-tone averages at high frequencies in each ear (p < 0.05). The rates of reproducibility in TEOAE testing were significantly lower in patients with AS (p = 0.03). The signal-to-noise rates of the response values were lower at all frequencies in patients with AS, but a statistically significant difference was only observed at 2, 3 and 4 Hz (p < 0.05). ENG revealed pathologies in 11 patients with AS (34%), 8 of which were central (25%) and 3 of which were peripheral (9%). No correlation was found between cochleovestibular dysfunction and age, sex, disease duration, activity and medication taken. This study demonstrated that there is an association between AS and cochleovestibular dysfunction.

show abstract

“…Hearing loss has been sporadically described in all of the systemic vasculitides, yet it is most frequently associated with WG with up to 52% of patients having evidence of OM and 8% developing SNHL, 5 whereas patients with CSS have a lower prevalence of otitis (around 10%), but similar rates of SNHL 13 . Although not as well recognized, SNHL in Behçet's disease is reported in 23–55% of patients, suggesting that hearing loss represents the fourth most prevalent clinical symptom after oral and genital ulcers and skin lesions 3,14 …”

Section: Discussionmentioning

confidence: 99%

“…13 Although not as well recognized, SNHL in Behçet's disease is reported in 23-55% of patients, suggesting that hearing loss represents the fourth most prevalent clinical symptom after oral and genital ulcers and skin lesions. 3,14 Less commonly, otologic manifestations form the presenting complaint of patients with systemic vasculitis. Fauci et al, in their report on the long-term follow-up of 85 patients with WG, noted that 25% of patients present with serous OM and 6% with hearing loss as the initial sign of the disease.…”

Section: Discussionmentioning

confidence: 99%

Hearing Loss as the Presenting Feature of Systemic Vasculitis

Lidar

Carmel

Kronenberg

et al. 2007

Annals of the New York Academy of Sciences

View full text Add to dashboard Cite

Hearing loss, both sensorineural and conductive, is a well-recognized manifestation of systemic vasculitis, yet has only infrequently been described as its initial presentation. We describe three cases in which hearing loss preceded the diagnosis of systemic vasculitis by a period of a few weeks to more than 6 months. While steroid therapy was initiated immediately in one of the cases, comprehensive immunosuppressive therapy was given only after additional manifestations compatible with vasculitis appeared, allowing for a diagnosis of Wegener's granulomatosis in two of the cases and undifferentiated vasculitis, in the third. Hearing improved in all patients, albeit, residual dysfunction remained. Prompt referral for a complete rheumatologic workup in cases of unexplained hearing loss would allow for a timely diagnosis of a collagen vascular disease and facilitate early initiation of systemic therapy, possibly yielding better audiological results.

show abstract

Behçet’s disease and hearing loss

Cited by 42 publications

References 11 publications

Evaluation of hearing results in Behçet's disease

Evaluation of hearing results in Behçet's disease

Cochleovestibular Dysfunction in Ankylosing Spondylitis

Hearing Loss as the Presenting Feature of Systemic Vasculitis

Contact Info

Product

Resources

About